- Home
- ALZN vs KRKR Comparison
ALZN vs KRKR Comparison
Compare ALZN & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALZN
- KRKR
- Stock Information
- Founded
- ALZN 2016
- KRKR 2010
- Country
- ALZN United States
- KRKR China
- Employees
- ALZN N/A
- KRKR N/A
- Industry
- ALZN Medicinal Chemicals and Botanical Products
- KRKR Business Services
- Sector
- ALZN Health Care
- KRKR Consumer Discretionary
- Exchange
- ALZN Nasdaq
- KRKR Nasdaq
- Market Cap
- ALZN 7.0M
- KRKR 7.6M
- IPO Year
- ALZN 2021
- KRKR 2019
- Fundamental
- Price
- ALZN $1.31
- KRKR $3.05
- Analyst Decision
- ALZN Strong Buy
- KRKR
- Analyst Count
- ALZN 1
- KRKR 0
- Target Price
- ALZN $35.00
- KRKR N/A
- AVG Volume (30 Days)
- ALZN 130.8K
- KRKR 6.5K
- Earning Date
- ALZN 12-13-2024
- KRKR 12-05-2024
- Dividend Yield
- ALZN N/A
- KRKR N/A
- EPS Growth
- ALZN N/A
- KRKR N/A
- EPS
- ALZN N/A
- KRKR N/A
- Revenue
- ALZN N/A
- KRKR $41,654,350.00
- Revenue This Year
- ALZN N/A
- KRKR $45.99
- Revenue Next Year
- ALZN N/A
- KRKR $31.46
- P/E Ratio
- ALZN N/A
- KRKR N/A
- Revenue Growth
- ALZN N/A
- KRKR N/A
- 52 Week Low
- ALZN $1.25
- KRKR $3.03
- 52 Week High
- ALZN $15.06
- KRKR $14.88
- Technical
- Relative Strength Index (RSI)
- ALZN 32.89
- KRKR 30.00
- Support Level
- ALZN $1.25
- KRKR $3.04
- Resistance Level
- ALZN $1.47
- KRKR $3.71
- Average True Range (ATR)
- ALZN 0.11
- KRKR 0.25
- MACD
- ALZN -0.01
- KRKR -0.06
- Stochastic Oscillator
- ALZN 15.00
- KRKR 1.33
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.